US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist
  • 35.430
  • +0.360+1.03%
Trading Nov 25 12:23 ET
5.52BMarket Cap-354300P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-49.41%83.88M
357.05%73.47M
713.46%63.47M
8,290.02%233.66M
54,863.75%43.97M
176,298.94%165.82M
2,606.06%16.07M
287.05%7.8M
-58.36%2.79M
-96.55%80K
Operating revenue
-49.41%83.88M
357.05%73.47M
713.46%63.47M
8,290.02%233.66M
54,863.75%43.97M
176,298.94%165.82M
2,606.06%16.07M
287.05%7.8M
-58.36%2.79M
-96.55%80K
Cost of revenue
166.20%9.34M
334.54%8.3M
534.89%5.44M
5,232.45%14.13M
261,700.00%7.85M
175,350.00%3.51M
8,208.70%1.91M
261.60%857K
-66.46%265K
-98.57%3K
Gross profit
-54.08%74.54M
360.09%65.16M
735.49%58.03M
8,611.55%219.53M
46,805.19%36.12M
176,319.57%162.31M
2,380.39%14.16M
290.44%6.95M
-57.28%2.52M
-96.35%77K
Operating expense
30.68%62.1M
-4.23%56.35M
53.18%67.3M
1.81%198.9M
-6.78%48.6M
35.56%47.52M
48.91%58.84M
-36.00%43.94M
-44.29%195.36M
-45.15%52.14M
Selling and administrative expenses
28.07%41.97M
26.29%38.79M
23.20%34.58M
75.28%122.71M
38.43%31.15M
129.89%32.77M
143.04%30.72M
36.19%28.07M
-45.35%70.01M
-30.57%22.5M
-General and administrative expense
28.07%41.97M
26.29%38.79M
23.20%34.58M
75.28%122.71M
38.43%31.15M
129.89%32.77M
143.04%30.72M
36.19%28.07M
-45.35%70.01M
-30.57%22.5M
Research and development costs
36.50%20.14M
-37.57%17.56M
106.19%32.72M
-39.22%76.19M
-41.12%17.45M
-29.08%14.75M
4.64%28.12M
-66.97%15.87M
-43.68%125.35M
-52.69%29.64M
Operating profit
-89.17%12.43M
119.73%8.82M
74.94%-9.27M
110.70%20.63M
76.02%-12.49M
428.30%114.78M
-14.72%-44.67M
44.68%-36.99M
44.07%-192.84M
43.99%-52.06M
Net non-operating interest income expense
-191.73%-10.83M
-9.65%-3.98M
19.55%-2.29M
-23.79%-12.62M
15.06%-2.43M
-125.30%-3.71M
-20.22%-3.63M
-6.76%-2.84M
-80.76%-10.19M
-165.25%-2.86M
Non-operating interest expense
191.73%10.83M
9.65%3.98M
-19.55%2.29M
23.79%12.62M
-15.06%2.43M
125.30%3.71M
20.22%3.63M
6.76%2.84M
80.76%10.19M
165.25%2.86M
Other net income (expense)
-6.75%2.67M
147.76%1.71M
45.70%880K
7.43%5.04M
-53.89%890K
260.53%2.86M
-52.28%691K
15.49%604K
103.51%4.7M
180.52%1.93M
Other non- operating income (expenses)
-6.75%2.67M
147.76%1.71M
45.70%880K
7.43%5.04M
-53.89%890K
260.53%2.86M
-52.28%691K
15.49%604K
103.51%4.7M
180.52%1.93M
Income before tax
-96.25%4.27M
113.76%6.55M
72.78%-10.68M
106.59%13.06M
73.53%-14.03M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
Income tax
388K
-328K
29K
390K
390K
0
0
0
0
Net income
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
Net income continuous Operations
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
Minority interest income
Net income attributable to the parent company
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-96.59%3.88M
114.45%6.88M
72.71%-10.71M
106.39%12.67M
72.80%-14.42M
418.08%113.93M
-17.53%-47.61M
43.15%-39.23M
43.02%-198.34M
43.22%-52.99M
Basic earnings per share
-96.25%0.03
114.71%0.05
75.00%-0.07
106.16%0.09
74.36%-0.1
407.69%0.8
-13.33%-0.34
45.10%-0.28
44.49%-1.46
44.29%-0.39
Diluted earnings per share
-97.26%0.02
111.76%0.04
75.00%-0.07
106.16%0.09
74.36%-0.1
380.77%0.73
-13.33%-0.34
45.10%-0.28
44.49%-1.46
44.29%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -49.41%83.88M357.05%73.47M713.46%63.47M8,290.02%233.66M54,863.75%43.97M176,298.94%165.82M2,606.06%16.07M287.05%7.8M-58.36%2.79M-96.55%80K
Operating revenue -49.41%83.88M357.05%73.47M713.46%63.47M8,290.02%233.66M54,863.75%43.97M176,298.94%165.82M2,606.06%16.07M287.05%7.8M-58.36%2.79M-96.55%80K
Cost of revenue 166.20%9.34M334.54%8.3M534.89%5.44M5,232.45%14.13M261,700.00%7.85M175,350.00%3.51M8,208.70%1.91M261.60%857K-66.46%265K-98.57%3K
Gross profit -54.08%74.54M360.09%65.16M735.49%58.03M8,611.55%219.53M46,805.19%36.12M176,319.57%162.31M2,380.39%14.16M290.44%6.95M-57.28%2.52M-96.35%77K
Operating expense 30.68%62.1M-4.23%56.35M53.18%67.3M1.81%198.9M-6.78%48.6M35.56%47.52M48.91%58.84M-36.00%43.94M-44.29%195.36M-45.15%52.14M
Selling and administrative expenses 28.07%41.97M26.29%38.79M23.20%34.58M75.28%122.71M38.43%31.15M129.89%32.77M143.04%30.72M36.19%28.07M-45.35%70.01M-30.57%22.5M
-General and administrative expense 28.07%41.97M26.29%38.79M23.20%34.58M75.28%122.71M38.43%31.15M129.89%32.77M143.04%30.72M36.19%28.07M-45.35%70.01M-30.57%22.5M
Research and development costs 36.50%20.14M-37.57%17.56M106.19%32.72M-39.22%76.19M-41.12%17.45M-29.08%14.75M4.64%28.12M-66.97%15.87M-43.68%125.35M-52.69%29.64M
Operating profit -89.17%12.43M119.73%8.82M74.94%-9.27M110.70%20.63M76.02%-12.49M428.30%114.78M-14.72%-44.67M44.68%-36.99M44.07%-192.84M43.99%-52.06M
Net non-operating interest income expense -191.73%-10.83M-9.65%-3.98M19.55%-2.29M-23.79%-12.62M15.06%-2.43M-125.30%-3.71M-20.22%-3.63M-6.76%-2.84M-80.76%-10.19M-165.25%-2.86M
Non-operating interest expense 191.73%10.83M9.65%3.98M-19.55%2.29M23.79%12.62M-15.06%2.43M125.30%3.71M20.22%3.63M6.76%2.84M80.76%10.19M165.25%2.86M
Other net income (expense) -6.75%2.67M147.76%1.71M45.70%880K7.43%5.04M-53.89%890K260.53%2.86M-52.28%691K15.49%604K103.51%4.7M180.52%1.93M
Other non- operating income (expenses) -6.75%2.67M147.76%1.71M45.70%880K7.43%5.04M-53.89%890K260.53%2.86M-52.28%691K15.49%604K103.51%4.7M180.52%1.93M
Income before tax -96.25%4.27M113.76%6.55M72.78%-10.68M106.59%13.06M73.53%-14.03M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M
Income tax 388K-328K29K390K390K0000
Net income -96.59%3.88M114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M
Net income continuous Operations -96.59%3.88M114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M
Minority interest income
Net income attributable to the parent company -96.59%3.88M114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -96.59%3.88M114.45%6.88M72.71%-10.71M106.39%12.67M72.80%-14.42M418.08%113.93M-17.53%-47.61M43.15%-39.23M43.02%-198.34M43.22%-52.99M
Basic earnings per share -96.25%0.03114.71%0.0575.00%-0.07106.16%0.0974.36%-0.1407.69%0.8-13.33%-0.3445.10%-0.2844.49%-1.4644.29%-0.39
Diluted earnings per share -97.26%0.02111.76%0.0475.00%-0.07106.16%0.0974.36%-0.1380.77%0.73-13.33%-0.3445.10%-0.2844.49%-1.4644.29%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data